Short-term Outcomes and Predictors of Post-Surgical Seizures in Patients with Supratentorial Low-Grade Gliomas.

Hongxiang Jiang,Baohui Liu,Gang Deng,Fanen Yuan,Yinqiu Tan,Kun Yang,Lun Gao,Junmin Wang,Qianxue Chen

DOI: https://doi.org/10.1016/j.jocn.2019.12.034

IF: 2.116

2020-01-01

Journal of Clinical Neuroscience

Abstract:To explore the predictive factors and short-term outcomes of post-surgical seizures in patients with supratentorial low-grade gliomas (LGGs). A consecutive series of 70 supratentorial LGG patients with seizures were reviewed to determine the predictors and short-term outcomes of seizures. Univariate analyses and multivariate logistic regression analyses were performed to determine the predictive factors associated with postoperative seizure outcomes. We identified the preoperative seizure frequency threshold by plotting a receiver operating characteristic curve. A Kaplan-Meier curve was constructed to illustrate the seizure-free survival rate of our cohort over time. 54 patients who remained seizure free post-surgery were classified into the Engel class I, and the other 16 patients whose seizures relapsed were classified into Engel classes II-IV. Univariate and multivariate logistic regression analyses showed that the preoperative seizure frequency (X-2 = 16.069, P = 0.001), extent of resection (X-2 = 5.031, P = 0.025), IDH1 mutation (X-2 = 4.435, P = 0.035) and adjuvant chemotherapy of temozolomide (X-2 = 4.081, P = 0.043) were related to the postoperative short-term seizure outcome. The ROC curve indicated that the area under the curve for the preoperative seizure frequency test was 0.805 (95% confidence interval 0.690-0.920, p < 0.05), which corresponded to an optimal threshold of 2 preoperative seizures. The IDHlwT status and adjuvant chemotherapy with temozolomide were related to a better postoperative seizure outcome. Within the first year after the surgical resection, seizures reoccurred among 16 patients (22.9%) with a mean time of 10.8 months. The preoperative seizure frequency, extent of resection, IDH1 status, and adjuvant chemotherapy with temozolomide were predictive factors of short-term postoperative seizure outcomes for supratentorial LGGs. To obtain a favorable seizure outcome, early intervention and removal are warranted. IDH1 mutation is the predictive biomarker of postoperative seizure outcomes. The adjuvant chemotherapy with temozolomide appears to be associated with better seizure outcomes, and it may be useful in helping to control the postoperative seizures. (C) 2019 Published by Elsevier Ltd.